SCHEMBL14636005

SCHEMBL14636005

CCOc1ccn(C2CCN(C(=O)OC(C)(C)C)CC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 11/20 0.50
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HCAR1 Q9BXC0 1/20 0.43
TP53 P04637 1/20 0.43
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN6 P29350 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24265551 0.86 STS (0.48) GPR119KDM4EGAAPKM
SCHEMBL29945930 0.85 GPR119 (0.54) GPR119TP53
SCHEMBL29946016 0.84 GPR119 (0.46) GPR119MEN1USP2ALDH1A1GAA
SCHEMBL31273679 0.82 GPR119 (0.46) GPR119KDM4EALDH1A1MAPTMAPK1
SCHEMBL14635882 0.82 GPR119 (0.48) GPR119KDM4EMEN1ALDH1A1GAA
SCHEMBL29945962 0.82 GPR119 (0.53) GPR119TP53
SCHEMBL29946022 0.82 NR3C1 (0.44) GPR119MEN1USP2ALDH1A1GAA
SCHEMBL15950964 0.82 GPR119 (0.50) GPR119ALDH1A1MAPTMAPK1KMT2A
SCHEMBL29945868 0.82 GPR119 (0.48) GPR119KDM4EALDH1A1MAPTMAPK1
SCHEMBL29946041 0.81 GPR119 (0.45) GPR119MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049419-A1 PYRAZOLYL COMPOUNDS AS EMOPAMIL BINDING PROTEIN INHIBITORS GENZYME CORPORATION (US) 2025-03-06 WO disclosed
WO-2013010453-A1 CHEMOKING RECEPTOR ANTAGONISTS ABBOTT LABORATORIES (US) 2013-01-24 WO disclosed